AD is associated with the accumulation of amyloid-beta plaques, tau tangles, neuroinflammation, synaptic dysfunction, and neuronal loss among other pathologies and these various mechanisms likely potentiate the progression of the disease in differing degrees in different individuals thus raising the need for personalized treatment approaches guided by an individualized profile of the disease. The gene discussed is MAPT; the disease is Alzheimer disease.